Eric Bernstein

OX40 Is a Potent Immune-Stimulating Target in Late-Stage Cancer Patients

Brendan D. Curti, Magdalena Kovacsovics-Bankowski, Nicholas P. Morris et al. · Cancer Research · 2013 · 509 citations

Medicine, Immunology, Oncology +15

Galunisertib plus neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer: a single-arm, phase 2 trial

Tomoko Yamazaki, Andrew J. Gunderson, Miranda Gilchrist et al. · The Lancet Oncology · 2022 · 142 citations

Medicine, Oncology, Surgery +16

A Randomized, Placebo-Controlled, Multicenter, Biomarker-Selected, Phase 2 Study of Apricoxib in Combination with Erlotinib in Patients with Advanced Non–Small-Cell Lung Cancer

Barbara J. Gitlitz, Eric Bernstein, Edgardo S. Santos et al. · Journal of Thoracic Oncology · 2014 · 35 citations · Full text

Medicine, Oncology, Pharmacology +12

Evaluation of nuclear factor κB and chemokine receptor CXCR4 co‐expression in patients with prostate cancer in the Radiation Therapy Oncology Group (RTOG) 8610

Meena Okera, Kyoungwha Bae, Eric Bernstein et al. · British Journal of Urology · 2010 · 22 citations · Full text

Medicine, Oncology, Urology +17

A phase II study of enzastaurin in combination with erlotinib in patients with previously treated advanced non-small cell lung cancer

Christelle Clément-Duchêne, Ronald B. Natale, Thierry Jahan et al. · Lung Cancer · 2012 · 13 citations · Full text

Medicine, Oncology, Pharmacology +13